21573-16-0 Usage
Description
Pyrimidine, 2-amino-5-cyclopropyl(8CI) is a chemical compound with the molecular formula C6H7N3. It belongs to the pyrimidine family and is characterized by a cyclopropyl group attached to the 5th position of the pyrimidine ring. This unique structure and properties make it an important building block for the synthesis of novel compounds with potential pharmacological applications.
Uses
Used in Pharmaceutical Research and Drug Development:
Pyrimidine, 2-amino-5-cyclopropyl(8CI) is used as a key component in pharmaceutical research and drug development due to its potential biological activities. Its antimicrobial and antifungal properties make it a promising candidate for the development of new therapeutic agents.
Used in Antimicrobial Applications:
Pyrimidine, 2-amino-5-cyclopropyl(8CI) is used as an antimicrobial agent for its ability to inhibit the growth of various microorganisms, making it a valuable tool in the fight against bacterial and fungal infections.
Used in Antifungal Applications:
Pyrimidine, 2-amino-5-cyclopropyl(8CI) is used as an antifungal agent for its potential to treat fungal infections, offering a new avenue for the development of antifungal medications.
Used in Synthesis of Novel Compounds:
Pyrimidine, 2-amino-5-cyclopropyl(8CI) is used as a building block in the synthesis of novel compounds with potential pharmacological applications, contributing to the discovery of new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 21573-16-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,5,7 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 21573-16:
(7*2)+(6*1)+(5*5)+(4*7)+(3*3)+(2*1)+(1*6)=90
90 % 10 = 0
So 21573-16-0 is a valid CAS Registry Number.
21573-16-0Relevant articles and documents
PRMT5 INHIBITORS
-
Page/Page column 42, (2021/06/26)
The present invention provides a compound selected from: compounds A, B, C, D and the pharmaceutically acceptable salts, esters, and prodrugs thereof, which are PRMT5 inhibitors. Also provided are methods of making compounds disclosed herein, pharmaceutic
INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF
-
, (2019/09/30)
The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
